A Review on the Mechanisms Involved in the Immunopathogenesis of SARS-CoV-2
M Farzanehpour, MR Karimi, P Rezayat… - Journal of Military …, 2020 - eprints.bmsu.ac.ir
Coronaviruses belong to the Coronaviridae family and three SARS-CoV, MERS-CoV and
SARS-CoV-2 pathogens are found in this family, all of which cause respiratory disorders in …
SARS-CoV-2 pathogens are found in this family, all of which cause respiratory disorders in …
[HTML][HTML] Molecular pathways involved in COVID-19 and potential pathway-based therapeutic targets
M Farahani, Z Niknam, LM Amirabad… - Biomedicine & …, 2022 - Elsevier
Deciphering the molecular downstream consequences of severe acute respiratory
syndrome coronavirus (SARS-CoV)− 2 infection is important for a greater understanding of …
syndrome coronavirus (SARS-CoV)− 2 infection is important for a greater understanding of …
The immune response and effectiveness of COVID-19 therapies
Abstract Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) is highly pathogenic with relatively high mortality …
syndrome coronavirus 2 (SARS-CoV-2) is highly pathogenic with relatively high mortality …
Inflammatory pathways and potential therapies for COVID-19: A mini review
AM Dabbish, N Yonis, M Salama… - European Journal …, 2021 - journals.sagepub.com
The public health crisis of the novel coronavirus disease (COVID-19) is alarming since
January 2020. COVID-19 genome (SARS-CoV-2) is related to other highly pathogenic …
January 2020. COVID-19 genome (SARS-CoV-2) is related to other highly pathogenic …
[HTML][HTML] Immunomodulatory agents for COVID-19 treatment: possible mechanism of action and immunopathology features
The novel coronavirus pandemic has emerged as one of the significant medical-health
challenges of the current century. The World Health Organization has named this new virus …
challenges of the current century. The World Health Organization has named this new virus …
[HTML][HTML] Immunological aspects of COVID-19: What do we know?
TV Velikova, SV Kotsev, DS Georgiev… - World journal of …, 2020 - ncbi.nlm.nih.gov
The newly emerged coronavirus (severe acute respiratory syndrome coronavirus 2 SARS-
CoV-2) and the disease that it causes coronavirus disease 2019 (COVID-19) have changed …
CoV-2) and the disease that it causes coronavirus disease 2019 (COVID-19) have changed …
[HTML][HTML] Molecular mechanisms involved in pathogenicity of SARS-CoV-2: Immune evasion and implications for therapeutic strategies
H Latifi-Pupovci - Biomedicine & Pharmacotherapy, 2022 - Elsevier
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused the outbreak of
unusual viral pneumonia that emerged in late 2019 in the city of Wuhan, China. Since then …
unusual viral pneumonia that emerged in late 2019 in the city of Wuhan, China. Since then …
[HTML][HTML] Cellular and molecular pathways of COVID-19 and potential points of therapeutic intervention
JP Hussman - Frontiers in pharmacology, 2020 - frontiersin.org
With the objective of linking early findings relating to the novel SARS-CoV-2 coronavirus
with potentially informative findings from prior research literature and to promote …
with potentially informative findings from prior research literature and to promote …
[HTML][HTML] Immunological perspectives on the pathogenesis, diagnosis, prevention and treatment of COVID-19
Y Ni, A Alu, H Lei, Y Wang, M Wu, X Wei - Molecular biomedicine, 2021 - Springer
Abstract Coronavirus disease 2019 (COVID-19) is an acute respiratory disease caused by
severe acute respiratory syndrome coronavirus 2 (SARS-COV-2). COVID-19 can spread to …
severe acute respiratory syndrome coronavirus 2 (SARS-COV-2). COVID-19 can spread to …